NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from EHZ Peptides? Mail in a sample (US only) and let us test it.

Test my supply
71%
Finnrick rating
#203 of 345 ranked vendors
51 of 65 classifiable tests passed
methodology · Purity focus
Finnrick analysis

EHZ Peptides' purity-focused record is led by Retatrutide and mostly solid Tirzepatide, with recent tests showing recovered identity, purity, and fill after earlier misses. Weakness is dispersed into BPC-157 purity/underfill failures and a GHK-Cu identity failure; evidence is recent but batch identifiers are often absent, limiting traceability.

methodology →
vendor intelligence report
Vendor Intelligence Report: EHZ Peptides

The investigation follows a WhatsApp-first seller with an unregistered obvious domain, no Delaware entity, and a gated PepChat lead. It also documents batch-ID gaps, brand-confusion risk, and a clean public affiliate scan with closed channels unresolved.

22 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.63
91%
31
2
Tirzepatide
$0.41
83%
15
3
GHK-Cu
$0.04
82%
7
4
BPC-157
$0.55
50%
6
5
Tesamorelin
$1.55
37%
6
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%13 Dec 2025: 66%13 Dec 2025: 66%17 Dec 2025: 65%17 Dec 2025: 65%17 Dec 2025: 66%7 Jan 2026: 66%7 Jan 2026: 65%7 Jan 2026: 65%9 Jan 2026: 66%26 Jan 2026: 66%26 Jan 2026: 67%26 Jan 2026: 67%26 Jan 2026: 67%9 Feb 2026: 67%10 Feb 2026: 67%10 Feb 2026: 67%10 Feb 2026: 67%10 Feb 2026: 68%15 Feb 2026: 68%20 Feb 2026: 69%20 Feb 2026: 69%20 Feb 2026: 69%4 Mar 2026: 69%6 Mar 2026: 70%6 Mar 2026: 70%6 Mar 2026: 70%6 Mar 2026: 71%28 Apr 2026: 71%16 Jun 2026: 71%13 Jul 2026: 72%13 Jul 2026: 72%13 Jul 2026: 72%13 Jul 2026: 72%17 Jul 2026: 73%21 Jul 2026: 72%7 Sept 2026: 72%9 Sept 2026: 73%9 Sept 2026: 72%10 Sept 2026: 71%14 Sept 2026: 72%28 Sept 2026: current 71%66%71%71%Dec 25Sep 26
Free peptide testing

Ordered peptides from EHZ Peptides? Mail in a sample (US only) and let us test it.

Test my supply
EHZ Peptides test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
14 Sep 2026
Pass
Retatrutide
lab nameView COA
10 Sep 2026
Fail
Tesamorelin
lab nameView COA
9 Sep 2026
Fail
GHK-Cu
lab nameView COA
9 Sep 2026
Pass
BPC-157
lab nameView COA
7 Sep 2026
Pass
Retatrutide
lab nameView COA
21 Jul 2026
Fail
Tesamorelin
lab nameView COA
17 Jul 2026
Pass
Retatrutide
lab nameView COA
13 Jul 2026
Fail
Tesamorelin
lab nameView COA
13 Jul 2026
Pass
GHK-Cu
lab nameView COA
13 Jul 2026
Pass
Retatrutide
lab nameView COA
1-10 of 65

About EHZ Peptides test results from Finnrick

EHZ Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 65 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible EHZ Peptides peptides in this dataset are Retatrutide (31 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 65 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from EHZ Peptides? Mail in a sample (US only) and let us test it.

Test my supply